| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $2.10 | $1.59 | $1.66 | $1.69 | $1.63 | $1.08 | $1.36 | $1.19 |
| EPS (Diluted) | $2.08 | $1.57 | $1.64 | $1.67 | $1.62 | $1.08 | $1.35 | $1.18 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $32.1B | $32.1B | $27.6B | $26.9B | $25.8B | $25.9B | $21.9B | $20.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $28.6B | $28.9B | $24.8B | $24.4B | $23.1B | $23.3B | $19.5B | $18.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.5B | $3.2B | $2.8B | $2.6B | $2.7B | $2.6B | $2.3B | $2.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.4B | $0.4B | $0.6B | $0.3B | $0.2B | $0.1B | $0.3B |
| Investing Cash Flow | $-0.1B | $1.6B | $-0.8B | $-1.5B | $-0.2B | $-2.5B | $-0.9B | $-0.7B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.2B | $-1.5B | $0.3B | $-0.0B | $-0.3B | $3.7B | $0.8B | $0.5B |